Sara Volorio

3.1k total citations
26 papers, 1.1k citations indexed

About

Sara Volorio is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Sara Volorio has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 9 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Sara Volorio's work include Genetic factors in colorectal cancer (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Sara Volorio is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), BRCA gene mutations in cancer (6 papers) and Cancer Genomics and Diagnostics (5 papers). Sara Volorio collaborates with scholars based in Italy, United States and United Kingdom. Sara Volorio's co-authors include Myriam Alcalay, Loris Bernard, Pier Giuseppe Pelicci, Emanuela Colombo, Lucilla Luzi, Salvatore Pece, Lorenzo Spaggiari, Giuseppe Pelosi, Pier Paolo Di Fiore and Giuseppe Viale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Sara Volorio

26 papers receiving 1.1k citations

Peers

Sara Volorio
Jennifer Cain United States
Vadym Zaberezhnyy United States
Jorge DiMartino United States
Cornelius Schmaltz United States
Paloma García United Kingdom
John Nip United States
Sara Volorio
Citations per year, relative to Sara Volorio Sara Volorio (= 1×) peers Catherine Frelin

Countries citing papers authored by Sara Volorio

Since Specialization
Citations

This map shows the geographic impact of Sara Volorio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Volorio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Volorio more than expected).

Fields of papers citing papers by Sara Volorio

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Volorio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Volorio. The network helps show where Sara Volorio may publish in the future.

Co-authorship network of co-authors of Sara Volorio

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Volorio. A scholar is included among the top collaborators of Sara Volorio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Volorio. Sara Volorio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tibiletti, Maria Grazia, Ileana Carnevali, Valeria Pensotti, et al.. (2025). From Therapy to Cancer Prevention Using HRD Testing on Patients with High-grade Ovarian Cancer. Cancer Prevention Research. 18(7). 393–400. 1 indexed citations
2.
Brignola, C., Sara Volorio, Giovanna De Vecchi, et al.. (2023). De novo germline pathogenic variant in Lynch Syndrome: A rare event or the tip of the iceberg?. Tumori Journal. 110(1). 69–73. 4 indexed citations
3.
Tibiletti, Maria Grazia, Ileana Carnevali, Valeria Pensotti, et al.. (2022). OncoPan®: An NGS-Based Screening Methodology to Identify Molecular Markers for Therapy and Risk Assessment in Pancreatic Ductal Adenocarcinoma. Biomedicines. 10(5). 1208–1208. 4 indexed citations
4.
Catucci, Irene, Silvia Casadei, Yuan Chun Ding, et al.. (2016). Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2. Breast Cancer Research and Treatment. 160(1). 121–129. 8 indexed citations
5.
Belloni, Elena, Paolo Veronesi, Sara Volorio, et al.. (2015). Whole exome sequencing identifies driver mutations in asymptomatic computed tomography-detected lung cancers with normal karyotype. Cancer Genetics. 208(4). 152–155. 9 indexed citations
6.
Salsano, Ettore, Gloria Bedini, Loris Bernard, et al.. (2013). An autoinflammatory neurological disease due to interleukin 6 hypersecretion. Journal of Neuroinflammation. 10(1). 29–29. 13 indexed citations
7.
Catucci, Irene, Roni Milgrom, Anya Kushnir, et al.. (2012). Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families. Familial Cancer. 11(3). 483–491. 24 indexed citations
8.
Grassi, Anna, Cinzia Segala, Fabio Iannelli, et al.. (2010). Ultradeep Sequencing of a Human Ultraconserved Region Reveals Somatic and Constitutional Genomic Instability. PLoS Biology. 8(1). e1000275–e1000275. 23 indexed citations
9.
Catucci, Irene, Paolo Verderio, Sara Pizzamiglio, et al.. (2010). The CASP8 rs3834129 polymorphism and breast cancer risk in BRCA1 mutation carriers. Breast Cancer Research and Treatment. 125(3). 855–860. 10 indexed citations
10.
Belloni, Elena, Paolo Veronesi, Carla Micucci, et al.. (2010). Genomic characterization of asymptomatic CT-detected lung cancers. Oncogene. 30(9). 1117–1126. 6 indexed citations
11.
Colaluca, Ivan Nicola, Giovanni D’Ario, Maddalena Donzelli, et al.. (2009). Alterations of the Notch pathway in lung cancer. Proceedings of the National Academy of Sciences. 106(52). 22293–22298. 317 indexed citations
12.
Vecchi, Giovanna De, Paolo Verderio, Sara Pizzamiglio, et al.. (2008). The p53 Arg72Pro and Ins16bp polymorphisms and their haplotypes are not associated with breast cancer risk in BRCA-mutation negative familial cases. Cancer Detection and Prevention. 32(2). 140–143. 17 indexed citations
13.
Mariano, Angela, Emanuela Colombo, Lucilla Luzi, et al.. (2006). Cytoplasmic localization of NPM in myeloid leukemias is dictated by gain-of-function mutations that create a functional nuclear export signal. Oncogene. 25(31). 4376–4380. 56 indexed citations
14.
Carro, Maria Stella, Fabio M. Spiga, Micaela Quarto, et al.. (2006). DEK Expression is Controlled by E2F and Deregulated in Diverse Tumor Type. Cell Cycle. 5(11). 1202–1207. 95 indexed citations
15.
Lyons, Robert, et al.. (2003). The DNA Sequence Quality Machine at IFOM: A Simple Web-based Tool for Quantitative Assessment of Sequencing Reactions. DNA sequence. 14(4). 327–330. 1 indexed citations
16.
Dell’Agnola, Chiara, Cristina Rabascio, Patrizia Mancuso, et al.. (2002). In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue. Experimental Hematology. 30(8). 905–914. 32 indexed citations
17.
Biunno, Ida, Loris Bernard, Monica Cattaneo, et al.. (2000). SEL1L , the human homolog of C. elegans sel-1 : refined physical mapping, gene structure and identification of polymorphic markers. Human Genetics. 106(2). 227–235. 24 indexed citations
18.
Reymond, Alexandre, Sara Volorio, Giuseppe Merla, et al.. (1999). Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. Oncogene. 18(51). 7244–7252. 62 indexed citations
19.
Porfirio, Berardino, Marco Seri, Francesco Caroli, et al.. (1998). A method for point mutation analysis that links SSCP and dye primer fluorescent sequencing. Molecular and Cellular Probes. 12(3). 125–131. 4 indexed citations
20.
Volorio, Sara, György Simon, Monica Repetto, et al.. (1998). Sequencing Analysis of Forty-Eight Human Image cDNA Clones Similar to Drosophila Mutant Protein. DNA sequence. 9(5-6). 307–315. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026